Independence Bank of Kentucky’s Opiant Pharmaceuticals, Inc. Common Stock OPNT Stock Holding History

Independence Bank of Kentucky’s Portfolio OPNT Stock Details OPNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-100	Closed	-$1K	–	349
2019 Q1	$1K	Hold	100	–	–	﹤0.01%	328
2018 Q4	$1K	Hold	100	–	–	﹤0.01%	349
2018 Q3	$2K	Hold	100	–	–	﹤0.01%	359
2018 Q2	$1K	Hold	100	–	–	﹤0.01%	306
2018 Q1	$2K	Buy	+100	New	+$2.16K	﹤0.01%	378

Other funds holding OPNT

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Fondren Management Houston, Texas $16.9M AUM 5.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

GIP

Granite Investment Partners El Segundo, California $1.95B AUM 49.89% 1-Year Est. Return

Advisor Group Phoenix, Arizona $14.5B AUM 28.91% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Independence Bank of Kentucky's OPNT Position: Q2 2019 in Review

Independence Bank of Kentucky sold out of Opiant Pharmaceuticals, Inc. Common Stock (OPNT) in Q2 2019, closing a stake of 100 shares — an estimated $1K sold.

Independence Bank of Kentucky first reported a position in OPNT in Q1 2018 and held it in 5 quarters. The position peaked at $2K in Q3 2018. 15 funds tracked by Wall St. Rank hold OPNT as of Q2 2019.

Independence Bank of Kentucky reported no remaining Opiant Pharmaceuticals, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
Independence Bank of Kentucky sold 100 Opiant Pharmaceuticals, Inc. Common Stock shares in Q2 2019, an estimated $1K.
Independence Bank of Kentucky first reported a position in Opiant Pharmaceuticals, Inc. Common Stock in Q1 2018 and held it in 5 quarters.
Independence Bank of Kentucky's Opiant Pharmaceuticals, Inc. Common Stock position peaked at $2K in Q3 2018.
15 funds tracked by Wall St. Rank held Opiant Pharmaceuticals, Inc. Common Stock as of Q2 2019.

Based on Independence Bank of Kentucky's 13F filing for Q2 2019, filed 23 Jul 2019.